Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis
Public ClinicalTrials.gov record NCT01690299. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3B, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Double-Dummy, Study Of The Efficacy And Safety Of Apremilast (CC-10004), Etanercept, And Placebo, In Subjects With Moderate To Severe Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will test the clinical effectiveness and safety of apremilast compared with placebo as well as etanercept compared with placebo in the same group of patients with moderate to severe plaque psoriasis.
Study identification
- NCT ID
- NCT01690299
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 250 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 1, 2012 (Actual)
- Primary completion
- Jul 3, 2014 (Actual)
- Completion
- Apr 4, 2016 (Actual)
- Last update posted
- Mar 15, 2022
2012 – 2016
United States locations
- U.S. sites
- 31
- U.S. states
- 20
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Research Center | Phoenix | Arizona | 85023 | — |
| Bakersfield Dermatology and Skin Cancer Medical Group | Bakersfield | California | 93309 | — |
| University of California Irvine-Department of Dermatology | Irvine | California | 92697 | — |
| University of California San Diego Medical Center | San Diego | California | 92122 | — |
| Horizons Clinical Research | Denver | Colorado | 80220 | — |
| George Washington University | Washington D.C. | District of Columbia | 20037 | — |
| Florida Center for Dermatology, PA | Jacksonville | Florida | 32204 | — |
| Florida Academic Dermatology Center | Miami | Florida | 33136 | — |
| International Dermatology Research | Miami | Florida | 33144 | — |
| Renstar Medical Research | Ocala | Florida | 34471 | — |
| Atlanta Dermatology, Vein and Research Center, PC | Alpharetta | Georgia | 30022 | — |
| NorthShore University HealthSystem | Skokie | Illinois | 60077 | — |
| Southern Illinois University School of Medicine | Springfield | Illinois | 62702 | — |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46256 | — |
| Dermatology and Advanced Aesthetics | Lake Charles | Louisiana | 70605 | — |
| Lawrence Green, MD, LLC | Rockville | Maryland | 20850 | — |
| Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| Robert Wood Johnson Medical School | Somerset | New Jersey | 08873 | — |
| Forest Hills Dermatology Group | Forest Hills | New York | 11375 | — |
| NYU Department of Dermatology | New York | New York | 10016 | — |
| University of North Carolina | Chapel Hill | North Carolina | 27516 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27104 | — |
| University Hospitals Case Medical Center | Cleveland | Ohio | 44106 | — |
| Ohio State University Medical Center | Columbus | Ohio | 43230 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | — |
| Tennesse Clinical Research Center | Nashville | Tennessee | 37215 | — |
| Teckton Research | Austin | Texas | 78745 | — |
| The Education and Research Foundation | Lynchburg | Virginia | 24501 | — |
| Virginia Clinical Research Inc | Norfolk | Virginia | 23507 | — |
| Dermatology Associates of Seattle | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01690299, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 15, 2022 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01690299 live on ClinicalTrials.gov.